previously reported that Na-K-Cl-cotransporter (NKCC) function and microsomal protein expression are both dramatically reduced late in human cytomegalovirus (HCMV) infection of a human fibroblast cell line . We now report DNA microarray data showing that no significant HCMV-dependent NKCC gene repression can be detected 30 h postexposure (PE) to the virus. Consequently, we used plasma membrane biotinylation and subsequent subcellular fractionation in combination with semiquantitative immunoblotting and confocal microscopy to investigate the possibility that intracellular redistribution of the NKCC protein after HCMV infection could be a cause of the HCMV-induced loss of NKCC ion transport function. Our results show that the lifetime of plasmalemmal NKCC protein in quiescent, uninfected MRC-5 cells is ϳ48 h, and Ͻ20% of the total expressed NKCC protein are in the plasma membrane. The remainder (ϳ80%) was detected as diffusely distributed, small punctate structures in the cytoplasm. Following HCMV infection: 1) NKCC protein expression in the plasmalemma was sharply reduced (ϳ75%) within 24 h PE and thereafter continued to slowly decrease; 2) total cellular NKCC protein content remained unchanged or slightly increased during the course of the viral infection; and 3) HCMV infection caused NKCC protein to accumulate in the perinuclear region late in the HCMV infection (72 h PE). Thus our results imply that, in the process of productive HCMV infection, NKCC protein continues to be synthesized, but, instead of being delivered to the plasma membrane, it is clustered in a large, detergentsoluble perinuclear structure. sodium-potassium-chloride-cotransporter; human fibroblast cell line; perinuclear accumulation THE NA-K-CL-COTRANSPORTER (NKCC) is a key component of the normal repertoire of housekeeping ion transporter proteins found in nearly every mammalian cell membrane (52). By using the transmembrane concentration gradients of Na ϩ and Cl Ϫ , it mediates the net uptake of Na ϩ , K ϩ , and Cl Ϫ into the cytosol, with the uptakes of K ϩ and Cl Ϫ occurring against their electrochemical gradients. The NKCC serves several important homeostatic functions. In many cells, it acts to generate and maintain an intracellular Cl Ϫ concentration that is higher than predicted from electrochemical equilibrium. The uptake of Na ϩ , K ϩ , and Cl Ϫ helps to generate an osmotic gradient that drives water movements across many epithelial cells. Cell shrinkage stimulates ion transport by the NKCC, and the resultant increase of cellular osmolyte content contributes to the process of regulatory volume increase (5, 25, 35, 36) .
Furthermore, the NKCC has been linked to early events in the normal mammalian cell cycle (48, 52) .
Human cytomegalovirus (human herpesvirus 5; HCMV) is an opportunistic pathogen infecting 60 -90% of the population. Although benign in healthy humans, HCMV is capable of causing severe disease in immunocompromised individuals (e.g., acquired immunodeficiency syndrome and organ transplant patients). It is also the leading cause of virally induced birth defects (e.g., Ref. 30) . In common with other viral infections, HCMV is known to perturb a number of host cell functions. The majority of these perturbations presumably optimize host cell functions and conditions to support viral persistence and productive viral replication (2, 4, 7, 28, 30) . These viral effects are the result of a controlled program of HCMV gene expression executed through virally activated cellular transcription factors. Two features of the HCMV infection process may make host cell ion transporters important optimization targets for this virus. Because the time of HCMV virion production is much longer than for other viruses (72-160 h for HCMV vs. 12 h for herpes simplex virus; Ref. 44) , host cell survival is very important. This suggests that maintenance of intracellular housekeeping functions in the face of significant viral demands on cellular metabolism will be critical to viral success. A second reason is that host cell optimization for HCMV includes a stereotypical increase of host cell size, volume, and intracellular water content (3, 18, 46) . This phenomenon is termed cytomegaly, and, because cell water content increases, it must be accompanied by an increase in intracellular osmolyte content. A nonspecific increase of osmolytes (e.g., via increased plasmalemmal leakiness) will presumably not suffice, given the long infection time of this virus.
Earlier studies demonstrated that cytomegaly and viral replication both strongly depend on the presence of extracellular Na ϩ . Therefore, it is not surprising that HCMV infection is characterized by significant effects on a variety of membrane ion transporters that mediate Na ϩ transmembrane movements. Examples include the sodium pump (3, 41, 46) and the Na ϩ /H ϩ exchanger (NHE) (9) , as well as the Cl Ϫ /HCO 3 Ϫ exchanger, which works in concert with the NHE to mediate net uptake of inorganic osmolytes promoting cell volume increases (37) . Fons et al. (18) reported that treatment of HCMV-infected cells with amiloride (an inhibitor of NHE) inhibited HCMV replication by almost two orders of magnitude. Similarly, incubation of HCMV-infected cells in low Na ϩ concentration ([Na ϩ ]) growth medium prevented cytomegaly and reduced viral replication (46) .
In light of the above, it was surprising to find that HCMV infection nearly abolishes NKCC ion transport (defined as bumetanide-sensitive Cl Ϫ uptake and loss) and the expression of the NKCC protein in the microsomal subfraction of infected human embryonic lung fibroblast cells (MRC-5 cells; Ref. 41 ). The bumetanide and Na ϩ sensitivities of intracellular [Cl Ϫ ], as well as net Cl Ϫ uptake and loss, were reduced by approximately threefold within 24 h postexposure (PE) to HCMV and abolished by 72 h PE. The drastically decreased NKCC function was paralleled, and could be explained, by a severe reduction (approximately ninefold) of NKCC protein expression in the membrane subfraction (determined 72 h PE; Ref. 41) .
NKCC occurs in two isoforms: NKCC1 and NKCC2 (15, 24, 52) . NKCC1 is particularly prominent in epithelial tissue, where it is known as the secretory isoform. However, it is also found in most other cell types (including fibroblasts), whereas NKCC2 distribution is limited to specific renal cell types. Posttranslational modifications (glycosylation and phosphorylation) appear to be critical to the ion transport function of both isoforms. NKCC1 is normally heavily glycosylated, and it has been suggested that a decreased level of glycosyslation will eliminate ion transport function of the NKCC protein by preventing its delivery to the plasma membrane (49) . Further posttranslational modification occurs when the NKCC is phosphorylated to activate its ion transport function. It is now well established that the degree of phosphorylation of both isoforms of the NKCC protein is directly related to the rate of NKCCmediated ion transport (23, 25, 34, 35, 52) .
The marked but unexpected effect of HCMV to reduce NKCC function and microsomal protein expression raises questions about the fate of this important ion transporter and its role in the productive HCMV infection. The present study follows NKCC gene and protein expression, NKCC plasmalemmal levels, and intracellular localization after HCMV infection. We report that the loss of NKCC function during HCMV infection is not a result of NKCC gene repression. Nevertheless, within 24 h of HCMV infection, plasmalemmal NKCC protein levels are drastically reduced and remain low thereafter. In contrast, plasmalemmal NKCC in mock-infected MRC-5 cells is stable for at least 24 h, with an approximate lifetime of ϳ48 h. Interestingly, Ͼ80% of the NKCC protein in mock-infected fibroblasts are intracellular and diffusely distributed, presumably in cytoplasmic vesicles. Despite the nearcomplete ablation of plasmalemmal NKCC protein, HCMV infection may lead to a slight increase of total cell content of NKCC protein. Confocal images of immunostained cells reveal that, at 72 h PE, NKCC protein accumulates in the perinuclear region of the HCMV-infected fibroblast. These results suggest that HCMV infection prevents NKCC protein from being inserted in the plasma membrane, leading to intracellular retention of NKCC protein, an effect that may be the result of virally induced changes in the intracellular NKCC protein trafficking.
EXPERIMENTAL PROCEDURES
Cell culture and HCMV infection. MRC-5 cells (American Type Culture Collection, Manassas, VA) derived from human lung fibroblasts (passages 19 -25) were cultured in MEM with Earle's salts, supplemented with 2 mM glutamine and 10% heat-inactivated FCS. T84 human carcinoma cell line (American Type Culture Collection) was grown in MEM and Ham's F-12 medium (1:1 vol/vol), containing 2.5 mM glutamine, 0.5 mM sodium pyruvate, and 5% FCS. Cells were grown in an incubator with a humidified atmosphere of 5% CO 2 in air at 37°C for several days to reach confluence.
HCMV strain AD169 (American Type Culture Collection) was used in these studies. A continually replenished stock of HCMV was cultured in confluent MRC-5 cells. At the appropriate time, the infected cells were lysed, and the infectivity of the resultant viral stock was assayed by plaque assay (37, 41) . For the studies reported here, HCMV infection was carried out by exposing the confluent MRC-5 cells to a virus stock at a multiplicity of infection of approximately three to five plaque-forming units (PFU/cell) for 1 h at 37°C. At such a multiplicity, Ͼ95% of the cells were productively infected. To control for nonspecific effects of the cell lysate portion of the viral stock, a parallel set of MRC-5 cells was always mock infected by a 1-h exposure to a lysate of uninfected MRC-5 cells. After the infectious period of exposure, both mock-and virus-treated cells were rinsed with PBS followed by fresh culture medium and returned to cell culture for various PE times.
Gel electrophoresis and Western blotting. Western blot analysis was performed as described in detail in Maglova et al. (41) . Protein samples and prestained molecular mass markers were denatured in SDS reducing buffer for 20 min at 65°C. The samples were then electrophoretically separated on 7.5% SDS gel, and the resolved proteins were transferred to a polyvinylidene membrane. The resultant blots were incubated in 5% nonfat milk overnight at 4°C and were subsequently incubated with the monoclonal anti-NKCC antibody T4 (Developmental Studies Hybridoma Bank, Iowa City, IA) for 1 h at room temperature and horseradish peroxidase-conjugated goat-antimouse IgG for 1 h at room temperature. The chemiluminescent signal was captured by using X-ray film (Fuji-RX) or directly on a Kodak Digital Science Image Station 440CF (Rochester, NY). Band densities were analyzed by using 1D Image Software (Kodak, Rochester, NY). All data are presented as either representative of several repeats or the means Ϯ SD for multiple repeats.
NKCC cell surface biotinylation and quantification. Cell surface biotinylation was used to label plasmalemmal NKCC protein in MRC-5 cells before and after HCMV infection. MRC-5 cells were grown to confluence. Cells were either mock or HCMV infected and, at appropriate times after infection, washed twice in PBS and once in borate buffer (in mM: 154 NaCl, 10 boric acid, 7.2 KCl, and 1.8 CaCl 2; pH 9.0). The surface plasma membrane proteins were then biotinylated by gently shaking the cells for 20 min with 3 ml of a biotinylation solution composed of borate buffer containing 1.5 mg of the membrane-impermeable agent, N-hydroxysulfosuccinimydyl-S,Sbiotin (Pierce Biotechnology, Rockford, IL). After 20 min, an additional 3 ml of the same biotinylation solution were added, and the cells were rocked for another 20 min. The cells were washed extensively with quenching buffer (in mM: 120 NaCl and 20 Tris; pH 7.4) to remove excess N-hydroxysulfosuccinimydyl-S,S-biotin and then washed twice with PBS. All labeling and washing manipulations were performed at 4°C. The cell surface biotinylation was verified by using confocal microscopy to visualize the cell membrane-bound biotin labeled with fluorescent-labeled streptavidin.
The biotinylated cells were scraped and solubilized in a small, defined volume of solubilization buffer (in mM: 60 HEPES, 150 NaCl, 3 KCl, 5 tri-sodium EDTA, 3 EGTA, and 1% Triton X-100; pH 7.4), sonicated for 20 s, agitated on a rotating rocker at 4°C for 30 min, and centrifuged at 12,000 g for 30 min to remove insoluble cellular debris. An aliquot of the resulting supernatant was retained to represent the total cell protein fraction (T). The protein content was determined by the Lowry assay by using a Bio-Rad DC protein assay kit (Bio-Rad Life Sciences, Hercules, CA). The remaining supernatant was incubated with avidin-agarose. At least two avidin incubations were performed to assure the extraction of all biotinylated proteins (B). After two consecutive avidin precipitations, the supernatant was retained as the residual fraction (R), and its volume was adjusted to the initial defined volume of solubilized cell protein (defined volume procedure). The avidin-agarose beads were washed five times in solubilization buffer, and bound proteins were eluted in 1/8 of the initial defined volume of sample buffer (110 mM Tris⅐HCl, 0.9% SDS, 0.8% EDTA, 5% glycerol, 5% 2-mercaptoethanol, and bromphenol blue), yielding a surface biotinylated fraction (B) that is 8ϫ concentrated compared with the T and R fractions.
A semiquantitative Western blot analysis was performed by using the T, R, and B fractions. Equal volumes of all three fractions were loaded on the gel (defined volume gel-loading procedure). The optical density (OD) values (in arbitrary densitometric units) of the NKCC bands for each treatment were normalized to the OD of the NKCC band in parallel mock-infected cells. By normalizing to mock-infected data, one can compare results from different experiments. Results were discarded when the total recovery of protein in the intracellular (R) plus surface fractions (B) was Ͻ80% or Ͼ98% of the total fraction (T).
Plasmalemmal NKCC lifetime. The cell surface biotinylation protocol described above was used. In this kind of experiment, the cell surface biotinylation was done in sterile conditions by using noninfected MRC-5 cells. Following their biotinylation, cells were returned to culture medium and cultured for an additional 24 -48 h. Biotinylated fractions were isolated at different times after the biotinylation procedure (1, 24, and 48 h), and semiquantitative Western blots were performed. In all experiments, the level of the biotinylated NKCC immediately after the biotinylation procedure (1 h) was used as the internal, normalizing control to compare data from different experiments.
Immunofluorescence and confocal microscopy. Confluent cells were grown on 12-mm coverslips and were either mock or HCMV infected. At the appropriate time after infection, the cells were fixed in cold methanol or were treated with 4% paraformaldehyde and permeabilized in 0.1% Triton X-100. After preblocking the cells in 20% normal goat serum, they were further incubated with the appropriate primary and fluorochrome-conjugated secondary antibodies. The coverslips were mounted on glass microscope slides, and cells were viewed by using a Zeiss Pascal Confocal microscope (Carl Zeiss, North American, Thornwood, NY). Images were processed by using the Zeiss Pascal software package.
Antibodies. For Western blot analyses, the anti-NKCC monoclonal antibody T4, designed and developed by Christian Lytle (University of California, Riverside, CA) and Bliss Forbush (Yale University, New Haven, CT), was used. The antibody was obtained from the Developmental Studies Hybridoma Bank (developed under the auspices of the National Institute of Child Health and Human Development and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA). For immunostaining studies, T4 and the recently available polyclonal anti-NKCC antibodies (TEF-S1 and TEF-S2), specific to the COOH-terminal epitope of NKCC1, were used. These latter antibodies were generous gifts of Dr. John Payne (University of California, Davis, CA) and Christian Lytle. To verify the NKCC colocalization with the perinuclear structure, another polyclonal anti-NKCC antibody (␣-wNT, specific to the NH 2-terminal epitope of NKCC1) was used (16) . The ␣-wNT antibody was kindly provided by Dr. Robert Turner, Membrane Biology Section, Gene Therapy and Therapeutics Branch, National Institutes of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD. In double-labeling immunostaining experiments, anti-immediate early antigen IE1 and 2 monoclonal antibody (Chemicon International, Temecula, CA) was used to stain the nucleus of the HCMV-infected MRC-5 cells.
RNA isolation and DNA microarray analysis. RNA was isolated from confluent MRC-5 cells that had been either mock or HCMV infected (30 and 72 h PE). Cells were rinsed with prewarmed PBS and then lysed by using TRIzol Reagent (Invitrogen Life Technologies, Carlsbad, CA). Residual genomic DNA was digested with RNA-free DNase I. DNase I and other protein contaminants were removed by two extractions with buffer-saturated phenol-chloroform. Total RNA was precipitated in propanol, washed in ethanol, and resuspended in diethylpyrocarbonate-treated water. An Oligotex mRNA Midi Kit (Qiagen, Valencia, CA) was used for isolation of mRNAs by following the manufacturer's instructions. The purity and integrity of the isolated mRNA were confirmed spectroscopically and electrophoretically by separation of mRNAs on a 1.2% agarose gel containing formaldehyde. Samples (4 g) of high-quality mRNAs were stored at Ϫ80°C and sent to Incyte Genome Systems (St. Louis, MO) for further RT-PCR, DNA amplification, Cy3/Cy5 labeling, and DNA microarray hybridization. Results were obtained from Incyte Human UniGEM version 2.0 (30 h PE) and Incyte Human UniGEM version 1.0 (72 h PE) DNA microarrays (30-h PE sample URL: http:// www.ncbi.nlm.nih.gov/geo/query/acc.cgi?accϭGSM9974; 72-h PE sample URL: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?accϭ GSM9973). The limit of statistically significant differential expression, as recommended by Incyte Genome Systems, was 1.74-fold.
RESULTS

DNA microarray data show no downregulation in NKCC gene expression during HCMV infection.
As outlined in the Introduction, there is evidence for significant changes of function and, in some cases, levels of expressed proteins for several host cell ion transporters throughout the replicative cycle of the HCMV. We initially pursued the idea that the effects of HCMV infection on NKCC and other host cell ion transporters were mediated by changes in gene expression levels by performing DNA microarray experiments. For these studies, we used the Human UniGEM V DNA microarray (Incyte Genome Systems, St. Louis, MO) in which 9,182 (at 30 h PE) and 7,075 (at 72 h PE) different human genes were probed. The genes included NKCC1, NHE1, Na-Cl cotransporter, and anion exchanger 2, as well as several other ion transporters. In these experiments, the gene expressions of mock-and HCMVinfected MRC-5 cells were compared at two different time points following HCMV infection (30 and 72 h PE; see EXPERIMENTAL PROCEDURES for details). With the use of a 1.74fold change as a statistically significant change (see above), the data revealed significant changes (both repression and overexpression) in 150 of the reported genes. However, as seen in Fig.  1 , HCMV infection caused no significant changes in the levels of mRNA expression for any of the four major ion-transporting integral membrane proteins, whose function and abundance our laboratory has studied late in the HCMV infection (9, (37) (38) (39) . These microarray data suggest that, although the HCMV infection has significant functional effects on these important homeostatic, plasmalemmal proteins, it does not significantly affect their gene expression. Therefore, the HCMV effects reported on NKCC ion transporter function and protein expression are likely to be the result of posttranslational modifications and/or changes in plasmalemmal NKCC protein delivery and intracellular localization.
Plasmalemmal NKCC lifetime in uninfected MRC-5 cells. We focused our studies on the posttranslational effects of HCMV infection on NKCC protein by first defining the plasmalemmal lifetime and intracellular localization of NKCC protein in uninfected, quiescent MRC-5 cells. Plasmalemmal NKCC lifetime was estimated by using biotinylation to label plasmalemmal proteins (see EXPERIMENTAL PROCEDURES) and Western blots to assess the amount of biotinylated NKCC protein still present at various times following the labeling procedure. Figure 2 shows the results of studies in which the OD of the biotinylated NKCC protein isolated from increasing amounts of total solubilized cellular protein are compared 1, 24, and 48 h after the biotinylation procedure. The NKCC protein was detected with the anti-NKCC antibody T4 (36) .
The calculated slopes of the plots of OD vs. micrograms of protein yield semiquantitative estimations of the amounts of biotinylated NKCC protein at these times following biotinylation. The data in Fig. 2, A and B , reveal no change in the amount of biotinylated NKCC protein between 1 and 24 h following plasmalemmal biotinylation. However, by 48 h after biotinylation, a significant decrease of the biotinylated NKCC protein was observed (Fig. 2, C and D) . Data from two experiments are collated in Fig. 2E , in which the regression slope data are normalized to the regression slope at 1 h postbiotinylation. These data demonstrate that the total amount of biotinylated NKCC, detected immediately after the procedure (the cells were kept at 4°C to prevent internalization) and 24 h later, does not change. However, these data do not reveal the subcellular location(s) of the biotinylated NKCC 24 and 48 h after biotinylation. Net degradation of biotinylated protein began later than 24 h after biotinylation, and by 48 h only ϳ25% of the original amount of NKCC was detected ( Fig. 2E ). Thus these data suggest that the normal lifetime of plasmalemmal NKCC in MRC-5 cells is ϳ48 h.
NKCC is predominantly an intracellular protein in uninfected MRC-5 cells. Examination of the results in Fig. 2 suggests another important property of the NKCC protein in MRC-5 cells. By comparing the OD of the NKCC signal of total cell protein with that of the biotinylated fraction, one can estimate the fraction of the total cellular NKCC protein that was in the plasmalemma during the biotinylation procedure. In Fig. 2A , total protein samples (30 g) from cells 1 and 24 h postbiotinylation (lanes 1 and 2) were run on the same gel with samples of the biotinylated fractions isolated from 30, 60, and 90 g total protein. Interestingly enough, comparison of the level of expression of the total NKCC in the MRC-5 cells (lane 1 or 2) to the level of biotinylated surface NKCC (lane 3 or 6) at the same treatment time (1 or 24 h) reveals that a very limited amount of the NKCC protein is biotinylated. To quantitatively estimate this difference, we plotted the OD of the T4-identified NKCC band vs. the total cellular protein and calculated the linear regression slope for the total cellular protein fraction (45.1 OD/g protein) and for the biotinylated protein subfraction (7.0 OD/g protein; see Fig. 2C ). These linear regression slopes permit an estimate of the relative amount of NKCC present on the plasmalemma to be ϳ16% of the total NKCC protein expressed in the MRC-5 cells. The data suggest the presence of a large intracellular NKCC pool in uninfected, quiescent MRC-5 cells.
More evidence that NKCC is predominantly localized intracellularly was provided by means of a different, more quantitative protocol in which both the biotinylated and the nonbiotinylated (presumably intracellular) protein fractions were isolated and directly compared. After the intact cells were biotinylated, total cell proteins were fractionated into biotinylated and residual or nonbiotinylated subfractions by using the defined volume technique (see EXPERIMENTAL PROCEDURES for details). This permits a direct comparison between the NKCC OD signals of the three fractions (total, T; biotinylated, B; and residual, R). Figure 3A is a representative Western blot analysis (n ϭ 3) of the three protein fractions by using the defined volume gel-loading procedure. We compared the OD of the NKCC bands from the three subfractions, taking into account that the biotinylated fraction is eightfold concentrated relative to the original cell lysate. In Fig. 3B , the OD data from the three experiments were normalized to the OD of the total NKCC fraction. This plot shows the fractions of biotinylated and nonbiotinylated (intracellular) NKCC to be ϳ12 and ϳ85%, respectively, of the total NKCC level detected in quiescent MRC-5 cells (Fig. 3B ). These data are in good agreement with the estimated level of biotinylated NKCC obtained from Fig. 2, A and B . Both types of studies indicated that Ͻ20% of total cellular NKCC protein resides in the plasmalemma of the MRC-5 cells. These results imply that the nonbiotin-labeled NKCC protein resides intracellularly, presumably in endosomal vesicles.
Past studies on the subcellular localization of the NKCC protein in epithelial tissues (e.g., T84 and parietal cells), using immunostaining, have shown that the protein is predominantly localized to the plasmalemmal region (e.g., Refs. 11, 16, 43) . To independently test the conclusions derived from our biotinylation studies, we undertook immunostaining studies on the MRC-5 cells as well as T84 cells. We used four different NKCC-specific antibodies (T4, TEF-S1 and -S2, and ␣-wNT). Figure 4 shows representative confocal images of both cell types by using two different anti-NKCC antibodies (T4 and TEF-S1; similar results were obtained by using TEF-S2 and ␣-wNT). For the MRC-5 cells (Fig. 4, A and B) , NKCCspecific staining is seen as small, punctate structures diffusely dispersed throughout the cytoplasm. This result suggests that the majority of the NKCC protein resides in small intracellular vesicles. In contrast, for the T84 cells ( Fig. 4, C and D) , both antibodies reveal that all of the NKCC protein is located in, and/or very near, the plasmalemma. Thus, using two independent approaches, we have demonstrated that, in uninfected MRC-5 cells, most of the NKCC protein is in the cytoplasm; semiquantitative biotinylation results suggest that Ն80% of the protein are intracellular, distributed throughout the cytoplasm in small, vesicle-like punctate structures.
Time course of the HCMV-induced decrease of plasmalemmal NKCC. We reported previously that, by 72 h PE, HCMV infection nearly abolished NKCC protein from a microsomal preparation of MRC-5 cells (41) . To confirm and extend this finding, we isolated biotinylated fractions from mock-and HCMV-infected cells at different time points during the progressively developing infection. The level of NKCC expression in the biotinylated fraction was assessed by using semiquantitative Western blot analysis (Fig. 5A ). In this case, we applied the defined-volume, gel-loading procedure (see EXPERIMENTAL PROCEDURES) to exclude the dilution factor effect resulting from the synthesis of viral proteins during the infection. In Fig. 5B , the OD of the resulting NKCC bands at the various time points (6 -96 h PE) are presented as a percentage of the OD of the NKCC band from mock-infected cells. The data presented in Fig. 5 show that HCMV infection causes no significant change in plasmalemmal NKCC protein until after 6 h PE. However, between 6 and 24 h PE, plasmalemmal NKCC expression was reduced by ϳ75% (not corrected for cell loss; see below) and continued to slowly decline throughout the remainder of the infection cycle. The observed data are Fig. 4 . MRC-5 and T-84 cells show different patterns of NKCC localization by immunostaining. NKCC protein in confluent MRC-5 cells and T-84 cells was visualized with different anti-NKCC antibodies by using confocal microscopy. A and B: MRC-5 cells immunostained with T4 and transcriptional enhancer factor (TEF)-S1 antibodies, respectively. C and D: T-84 cells immunostained with T4 and TEF-S1 antibodies, respectively. In all cases, the nonspecific immunostaining using only the secondary antibody was very low. Similar results for both cell types were obtained by using ␣-wNT and TEF-S2 antibodies (data not shown). Scale bar, 20 M. in good qualitative agreement with our functional data that showed a significant loss of bumetanide-and Na ϩ -sensitive Cl Ϫ uptakes and effluxes as early as 24 h PE (see Ref. 41) .
Effect of HCMV infection on total cellular NKCC expression. The effect of HCMV infection on total cellular NKCC protein content was determined. Western blot analyses were carried out on total cellular proteins solubilized by 1% Triton X-100 from mock-and HCMV-infected MRC-5 cells at different PE times. Figure 6 shows that the total level of NKCC protein expression was largely unchanged during the infection. Early in the infection cycle (24 h PE), there was a slight decrease (ϳ25%) in the total NKCC protein content. This decrease may be the result of a HCMV-induced cell loss, which we estimated to be ϳ25% (see Ref. 41) . If this is the case, the apparent recovery of NKCC protein content to the levels of mock-infected cells that occurred as the infection progressed (see Fig. 6 ) may represent a modest net increase (ϳ30 -40%) of NKCC protein content on a per-cell basis. Thus, despite the fact that HCMV infection results in the loss of NKCC ion transport function (41) and the ϳ90% reduction of NKCC protein from the plasmalemma (see Fig. 5B ), total cellular content of NKCC protein is unchanged or possibly even increased late in the HCMV infection.
This combination of results suggests that net synthesis of NKCC protein continues following HCMV infection, but the protein may be trafficked to a new (intracellular) destination, causing the loss of normal NKCC ion transporting function in the plasmalemma.
HCMV induces accumulation of NKCC in a perinuclear structure. Because HCMV infection results in decreased plasmalemmal, but not total cellular, content of NKCC protein, the most likely mechanism of the reduction of NKCC function is by altered NKCC protein delivery to the plasmalemma. Our observation that late in the infection NKCC can be detected only in a detergent-solubilized (1% Triton X-100) cell lysate suggests that NKCC should be located within the infected MRC-5 in a virus-inducible, detergent-soluble structure. These observations initiated additional confocal microscopy studies to learn whether any changes in the NKCC intracellular distribution can be observed late in the HCMV infection of MRC-5 cells. By 72 h PE (viral potency of 3-5 PFU/cell), almost all MRC-5 nuclei show the presence of NKCC clustering (red) very close to the enlarged, kidney bean-shaped nuclei (green; Fig. 7, A and B) . Cell nuclei of HCMV-infected MRC-5 cells were visualized by using an antibody to immediate early HCMV proteins expressed very early in the infection that are mainly limited to the cell nuclei (53) . A control experiment using fluorophore-conjugated IgG did not detect any clustering, confirming the specificity of the NKCC antibody (Fig. 7A,  top right corner) . The aggregated NKCC protein distribution observed in the HCMV-infected cells (Fig. 7) differs significantly from the diffuse distribution of this protein observed in uninfected cells (Fig. 4, A and B) . We have confirmed that the perinuclear structure contains NKCC protein by using several anti-NKCC antibodies made to the COOH and NH 2 termini of the protein (TEF-S1/S2, Fig. 7A, and ␣-wNT, Fig. 7B , respectively) for immunolocalization (see EXPERIMENTAL PROCEDURES for details).
The HCMV-induced perinuclear structure appears to be composed of numerous spherical structures, which may be more distinctly seen in Fig. 7C . Figure 7C presents a series of magnified views of an MRC-5 cell nucleus and the immediately adjacent region progressing along the z-axis. These images make it clear that the NKCC perinuclear structure resides very close to, but does not colocalize with, the nucleus (no yellow color is observed). Furthermore, Fig. 7C shows a number of individual spherical structures that are close to, but not part of, the perinuclear aggregation.
DISCUSSION
Previously, we reported that NKCC function and protein are expressed in MRC-5 cells, a model cell line for studying productive HCMV infection (41) . Pharmacological studies using the specific NKCC inhibitor bumetanide demonstrated that NKCC function is responsible for the majority of the Cl Ϫ uptake into Cl Ϫ -depleted MRC-5 cells. Furthermore, bumetanide-sensitive Cl Ϫ uptake required the presence of extracellular Na ϩ , reinforcing its designation as NKCC mediated. Following HCMV infection, the bumetanide-and Na ϩ -sensitive Cl Ϫ uptake was already significantly decreased by 24 h PE and abolished by 72 h PE. In the same study, Western blots revealed the presence of NKCC protein in the microsomal fraction of mock-infected cells. By 72 h after HCMV infection, microsomal NKCC protein content on a per-cell basis was reduced by ϳ90% (see Ref. 41 ). As microsomal protein comes from total cellular membranes under normal circumstances, the NKCC, being an integral membrane protein with a substantial Fig. 6 . HCMV infection has little effect on total cellular NKCC protein levels. A: representative Western blot of NKCC level of expression in total protein fractions isolated from mock (M) and HCMV-infected MRC-5 cells at different times after the infection (H). An equal number of confluent MRC-5 cells were mock and HCMV infected, and, at different times throughout the HCMV replicative cycle, they were lysed in an identical, defined volume. An identical aliquot of each was loaded onto the SDS gel. With the use of the T4 monoclonal antibody, the NKCC abundance was determined. B: the averages of data obtained from 2 separate experiments like those presented in A were expressed as percentages of the NKCC OD measured in mock-infected cells. Values are means Ϯ SD. hydrophobic region (50) , would be confined to the microsomal fraction. Thus viral inhibition of NKCC ion transport function and depletion of the microsomal fraction of this protein suggested that HCMV caused a generalized reduction of NKCC protein content, either as a result of NKCC gene repression or by reduction of host cell net protein synthesis and/or trafficking to the membrane. The present study addressed how this decrease of host cell microsomal NKCC protein is accomplished.
Reduced microsomal NKCC is not the result of NKCC message repression. The possibility that a virally directed repression of host cell protein messages causes the reduction of microsomal NKCC protein content was tested. The results of our DNA microarray analysis showed that, 30 h after HCMV infection (a time at which plasmalemmal NKCC is already greatly reduced; see Fig. 5 ), there was no significant effect on NKCC1 message levels (Fig. 1) . Similarly, the microarray results show no significant HCMV effects on the message levels of several other membrane ion transporters for which we have reported HCMV-induced functional changes (NHE: Ref. 9; Cl Ϫ /HCO 3 Ϫ exchanger, anion exchanger: Ref. 37 ; Na-Clcotransporter: Ref. 39 ). It is of interest that, in the case of the NHE, we have preliminary evidence that the increased function may be mediated by an increase in the protein levels of the NHE2 isoform relative to the NHE1 (38) .
Reduced microsomal NKCC cannot be solely the result of reduced net NKCC protein synthesis. We next tested whether the decrease of microsomal NKCC protein reflected the net decrease of total cellular NKCC protein content brought about by virally mediated effects on NKCC protein synthesis and/or degradation. A generalized reduction of host cell protein expression seems unlikely, as we have demonstrated increased function for several ion transport processes (i.e., the Na-K-ATPase, the NHE, and Cl Ϫ /HCO 3 Ϫ exchange; Refs. 3, 9, 37) and increased protein expression of the Na-K-ATPase (41) . In contrast to the approach of Maglova et al. (41) in which the NKCC protein content of a microsomal preparation was determined, for the present study, we solubilized total cell membrane proteins using Triton X-100 (see EXPERIMENTAL PROCE-DURES). As Fig. 6 clearly shows, HCMV infection does not result in a decrease of total, detergent-solubilized NKCC protein when one corrects for the cell loss of ϳ25% that occurs during the first 24 h PE (41) . In fact, our data suggest that, by 96 h PE, the content of NKCC protein per remaining HCMVinfected cell may have increased by as much as 30 -40% over that in the mock-infected control cells. This implies that net synthesis of the NKCC protein continues during the infection. The relative contributions of synthesis and degradation to the Fig. 7 . Confocal immunofluorescent images showing the perinuclear accumulation of NKCC protein in 99% of MRC-5 cells 72 h after HCMV infection. HCMV-infected cells were immunostained for NKCC (red) by using TEF-S1 polyclonal antibody (A) or ␣-wNT polyclonal antibody (B). In addition, an antibody to anti-immediate early viral proteins (green; MAb 810) was used to visualize the nuclei. A and C: inserted in the top right corner of A is an image of the nonspecific immunostaining using only fluorophore-conjugated secondary antibodies. Both images were taken and processed by using the same settings and conditions. Scale bar, 20 M. C: enlargement of an MRC-5 nucleus (enclosed in the box in A that is 20 M on a side) and its associated NKCC perinuclear accumulation, showing in a series of z-sections (0.5 M step) the relationship between the nucleus and the "clustered" NKCC protein. Note the lack of colocalization of the NKCC protein and nucleus. observed net increase of NKCC protein remain to be determined.
Despite the results just described, HCMV infection clearly caused functional inhibition of the NKCC (41) . An independent approach was taken to test whether the loss of plasmalemmal NKCC protein could account for the functional NKCC inhibition. The plasmalemmal subfraction of cellular NKCC protein was biotinylated and separated, and the amount was determined by using semiquantitative Western blotting. As seen in Fig. 5 , HCMV infection reduced the plasmalemmal component of NKCC protein by ϳ75% between 6 and 24 h PE. Plasmalemmal NKCC content continued to decrease as the infection progressed so that, by 96 h PE, plasmalemmal NKCC content was reduced ϳ90% relative to mock-infected cells.
To put this pathological, HCMV-induced rate of net loss of plasmalemmal NKCC protein into a physiological perspective, we estimated the turnover rate of plasmalemmal NKCC in uninfected cells. The amount of biotinylated NKCC protein remaining 24 and 48 h after the biotinylation procedure was used for this estimate. The changes were quantitatively assessed by comparing the linear regression slopes of the biotinylated fractions 24 and 48 h after biotinylation to the slope obtained immediately after the biotinylation procedure (1 h). Interestingly, there was no detectable change during the first 24 h after surface membrane biotinylation. However, by 48 h following biotinylation, ϳ75% of the biotinylated NKCC protein was degraded (compare Fig. 2, B and D) . It is possible that, during the lag period between biotinylation and degradation of the biotinylated NKCC protein, recycling of NKCC protein in and out of the plasmalemma occurs before its ultimate destruction. As discussed below, other workers have provided some evidence that NKCC protein may cycle in and out to the plasmalemma, perhaps depending on its phosphorylation state (11, 12, 23) . In summary, in uninfected MRC-5 cells, biotinylated NKCC protein is not degraded for at least 24 h but then disappears over the next 24 h, whereas, after HCMV infection, there is a net removal of plasma membrane (biotinylated) NKCC protein that is near completion 24 h PE. This suggests that the virus causes a significant change in trafficking of this integral membrane protein to the plasmalemma. At least part of the viral effect must involve enhanced endocytosis of the plasmalemmal NKCC. In fact, HCMV infection is known to cause an increased rate of endocytosis (20, 57) , and HCMV infection has been reported to reduce cell surface expression of EGF receptors (17) .
HCMV infection causes redistribution of NKCC protein within the cell. We have confirmed that HCMV infection causes the near-complete removal of plasmalemmal NKCC, while at the same time resulting in a slight increase in total cellular NKCC protein. To better understand this, we needed information on the normal subcellular distribution of the NKCC in our human fibroblast cell line. Two approaches were used to address the question of the cellular distribution of NKCC protein in uninfected fibroblasts.
By means of biotinylation and Western blotting protocols, we demonstrated that, in uninfected, quiescent MRC-5 cells, the large majority (ϳ80%) of total cellular NKCC protein is intracellular, not plasmalemmal (Յ20%; Figs. 2 and 3 ). Confocal imaging of immunostained, uninfected MRC-5 cells qualitatively confirms this conclusion. Furthermore, the confocal images show in uninfected cells that the intracellular NKCC protein is diffusely distributed throughout the intracellular space in very small, punctate structures, which we assume are vesicles (see Fig. 4, A and B) . By contrast, we confirm that, in an epithelial cell line, T84, the NKCC protein accumulates in, and very near to, the plasmalemma.
To date, studies on the normal subcellular distribution of NKCC1 have been limited to polarized epithelial cells where immunostaining techniques have detected NKCC1 predominantly on the plasma membrane (e.g., Ref. 43) . In contrast to the present finding in fibroblasts, D'Andrea et al. (11) showed that, for T84 cells (a human intestinal cell line), ϳ80% of cellular NKCC protein were located in the basolateral membrane. Our results (Fig. 4, C and D) are consistent with this conclusion. About 20% were localized to vesicle-like structures in the cytosolic region immediately subjacent to the basolateral membrane. These findings led to the suggestion that the cytoplasmic vesicles represent a "reserve" source of NKCC1 ion-transporting units that can be inserted into the plasmalemma in response to the appropriate signal (11, 12) . Similar vesicles have been reported for the NKCC2 isoform by using immunofluorescent techniques in epithelial cells isolated from the loop of Henle (45) . Forbush's group (23) used electron microscopy to demonstrate a significant pool of NKCC2 in cytoplasmic vesicles located just under the plasmalemma in cells of the thick ascending limb of the loop of Henle. They further showed that the phosphorylated transporter appears to be restricted to the apical cell membrane of the cells and suggested that NKCC phosphorylation may be necessary for NKCC2 protein translocation to the cell surface.
HCMV infection of MRC-5 cells leads to a perinuclear accumulation of NKCC protein. Our results clearly show that, following HCMV infection in MRC-5 cells, there is a remarkable change in the subcellular distribution of NKCC protein.
By 72 h PE, the plasmalemmal NKCC content was reduced by ϳ80 -85% (see Fig. 5B ), but the amount of intracellular NKCC protein was unchanged or slightly increased. In addition, intracellular NKCC protein was no longer diffusely distributed throughout the cytoplasm. Rather, it had aggregated into a relatively large perinuclear accumulation (see Fig. 7 ). Thus this perinuclear structure must represent the source of the detergent-soluble NKCC protein detected by Western blot analysis of HCMV-infected cells (e.g., Fig. 6 ). The detergent solubility suggests that the NKCC protein remains in a lipid bilayer membrane. Therefore, we assume the reason that we earlier reported NKCC to be depleted from the microsomal fraction (41) is because, in the absence of detergent, the perinuclear structure sediments at a low centrifugation rate.
Perinuclear accumulations of membrane and/or cytosolic proteins, termed "aggresomes" (e.g., Refs. 21, 22, 27) , have been reported in a variety of experimental or pathological situations. The term "conformational diseases" has been coined for diseases exhibiting such structures (e.g., Ref. 22 ). Aggresomes may represent cellular responses to misfolded or unassembled proteins (21, 29) . Aggresomes are envisaged to be holding stations that recruit chaperones and proteasomes for the purpose of degrading the defective proteins residing therein. Thus it is possible that HCMV infection results in the misfolding of the NKCC protein that, in turn, causes the protein to accumulate in an aggresome. This would explain the loss of plasmalemmal NKCC protein. However, we have three pieces of evidence that argue against the perinuclear structure being an aggresome. First, aggresomes are said to be detergent insoluble (27) , including being insoluble in Triton X-100 (21) , and, as we have shown in this report, the NKCC perinuclear structure is detergent soluble (see Figs. 5 and 6) . Second, the protein in aggresomes is believed to be deglycosylated (27) . The NKCC protein before and after HCMV infection runs at ϳ159 kDa (see Figs. 2, 5, and 6 ), whereas the unglycosylated NKCC protein has a predicted mass of ϳ130 kDa. Third, aggresomes are enclosed in a characteristic vimentin cage (21, 27) . We have been unable to demonstrate the presence of such a structure in HCMV-infected cells (LM Maglova, WE Crowe, and JM Russell, unpublished observations).
Alternatively, the perinuclear accumulation of NKCC protein may be associated with the perinuclear accumulation of viral proteins. Large DNA viruses cause perinuclear accumulations of viral proteins, and it has been suggested that these structures play a role in viral assembly (26) . In the specific case of HCMV, Britt's group (54, 55) has described a perinuclear structure containing at least six HCMV proteins that are ultimately found in the tegument and envelope of formed virions. Although these accumulations of viral proteins share some common features with aggresomes, they also have some very different properties. For instance, in common with aggresomes, the HCMV-induced structures have a characteristic perinuclear location and form around the microtubule organizing center. On the other hand, they are not surrounded by vimentin (see above), they are disrupted by nocodazole, and there is no evidence of colocalization with lysosomes (54, 55) . Thus it is of interest that we have reported preliminary evidence that the NKCC protein in the perinuclear structure is colocalized with several HCMV tegument proteins (40) . The possibility that host cell NKCC protein shares a structure with HCMV tegument and envelope proteins raises interesting possibilities as viral factories are said to tend to exclude host cell proteins (26) .
Is NKCC functional inhibition related to host cell K ϩ requirements and viral effects on the cell cycle? A number of investigators have noted that increases of uptake of K ϩ occur during the early portion of the mammalian cell cycle (e.g., Refs. 32, 42, 58) . A rise in intracellular [K ϩ ] ([K ϩ ] i ) may be important for mammalian cell growth and protein synthesis (31) . There are reports that mitogens stimulate functional NKCC activity (e.g., Refs. 8, 47) and that overexpression of the NKCC protein will stimulate cell proliferation (48) . In light of these findings, it is very interesting to note that HCMV infection stimulates the host cells to enter the cell cycle, but causes the cycle to halt at the G 1 /S interface (e.g., Refs. 6, 33; reviewed in Ref. 19 ). Presumably, this viral tactic serves the purpose of optimizing cellular conditions for viral DNA synthesis (56) while preventing host cell DNA synthesis. Halting the host cell cycle appears to be critical as cells that are able to continue through their normal cell cycle following HCMV infection undergo an abortive or nonreplicating viral infection (1) . We suggest that the downregulation of NKCC ion transport function may subserve the need of the virus to halt the cell cycle at the G 1 /S interface. This would help explain why the NKCC, a prime candidate to cause cell volume increase, is downregulated in HCMV-infected, cytomegalic cells. We (JM Russell, LM Maglova, and WE Crowe) have unpublished data showing that HCMV infection results in slight but significant decrease in [K ϩ ] i . Thus it is possible that NKCC inhibition occurs to prevent the increase of [K ϩ ] i that may normally occur during the early phase of the mammalian cell cycle. NKCC protein downregulation: a possible mechanism for HCMV-induced neurological birth defects. Congenital HCMV infection is now the leading cause of virally mediated neurological birth defects afflicting between 0.5 and 3% of all live births in the world (e.g., Ref. 10). In addition to mental retardation and learning disabilities, deafness often occurs in infants born to mothers infected with HCMV during their pregnancy. Although the central nervous system is the major target organ for tissue damage by HCMV infection in the developing fetus, little is known about the molecular mechanisms responsible for the pathogenesis of tissue damage of congenital cytomegalovirus infection. The results reported here may begin to offer an explanation for at least some of these pathological effects. Thus we have demonstrated that HCMV infection blocks NKCC function by causing its removal from the plasmalemma. It is becoming increasingly clear that this cation-chloride-coupled cotransport mechanism may play important roles in normal neuronal development and function (e.g., Ref. 13, 51) . For example, developmental studies have shown that various regions of the developing brain have carefully timed changes in the relative levels of expression of NKCC1 and the K-Cl cotransporter isoform 2. Thus it is possible that a congenital HCMV infection may result in neurological deficits as a result of disruption of this sequential change in dominance of the two cation-coupled cotransporters. In addition, it has been shown that the inner ear contains NKCC1 that is likely involved with the secretion of endolymph fluid. Mice whose NKCC1 gene has been knocked out demonstrate inner ear structural changes and deafness (14) . 
